Abstract
Giant pituitary adenomas (diameter >4 cm) are a challenge to treat, and there is no consensus on the optimal surgical strategy. We report here our experience in surgical management of these lesions. Adult patients with giant pituitary adenomas (n = 62; 54 non-functioning and eight hormone-secreting adenomas) who underwent surgical resection at our hospital from 2009 to 2015 were retrospectively reviewed. Surgical and clinical outcomes were analyzed. Single transsphenoidal and transcranial approaches were used in 43 (69.4%) and four (6.5%) patients, respectively. A combined transsphenoidal and transcranial approach was used in 13 patients (20.9%) and in two patients (3.2%), a transcranial procedure was followed 3 months later by a transsphenoidal approach. Greater than 90% resection was achieved in 47 cases (75.8%). During a mean follow-up period of 46.9 months, 49 patients (79%) showed improved visual impairment scores, while none experienced visual deterioration. There was no post-operative hemorrhage or mortality. A total of 27 patients (43.5%) received adjuvant medical and/or radiation therapy. At last follow-up, eight patients (12.9%) had recurrence. For giant pituitary adenoma, the transsphenoidal and transcranial approaches should be combined flexibly based on the characteristics of the tumor. In certain cases, a simultaneous combined approach can maximize tumor extirpation and lower the risk of swelling and bleeding of the residual tumor.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- GH:
-
Growth hormone
- GPA:
-
Giant pituitary adenoma
- KPS:
-
Karnofsky performance score
- MRI:
-
Magnetic resonance imaging
- NFPA:
-
Nonfunctioning pituitary adenoma
- PA:
-
Pituitary adenoma
- PRL:
-
Prolactin
- VIS:
-
Visual impairment score
References
Dehdashti AR, Ganna A, Karabatsou K, Gentili F (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62:1006–1015 (discussion 1015–1017)
Magro E, Graillon T, Lassave J, Castinetti F, Boissonneau S, Tabouret E, Fuentes S, Velly L, Gras R, Dufour H (2016) Complications related to the endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary macroadenomas in 300 consecutive patients. World Neurosurg 89: 442–453
Mamelak AN, Carmichael J, Bonert VH, Cooper O, Melmed S (2013) Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases. Pituitary 16:393–401
Powell M (2012) Microscope transsphenoidal surgery. Acta Neurochir (Wien) 154:913–917
Sinha S, Sharma BS (2010) Giant pituitary adenomas–an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg 24:31–39
Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M (2007) Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery 60:993–1002 (discussion 1003–1004)
Jeffreys RV (1989) The surgical treatment of large pituitary adenomas. Br J Neurosurg 3:147–152
Takakura K, Teramoto A (1996) Management of huge pituitary adenomas. Acta Neurochir Suppl 65:13–15
Wang RZ, Yin J, Su CB, Ren ZY, Yao Y, Tao W (2006) [Extended transsphenoidal operation for giant and invasive pituitary adenomas]. Zhonghua Wai Ke Za Zhi 44:1548–1550
Sanai N, Quinones-Hinojosa A, Narvid J, Kunwar S (2008) Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors. J Neurooncol 87:317–325
Nakao N, Itakura T (2011) Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci 18:71–75
Leung GK, Law HY, Hung KN, Fan YW, Lui WM (2011) Combined simultaneous transcranial and transsphenoidal resection of large-to-giant pituitary adenomas. Acta Neurochir (Wien) 153:1401–1408 (discussion 1408)
Zada G, Du R, Laws ER Jr (2011) Defining the “edge of the envelope”: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy. J Neurosurg 114:286–300
Dolenc VV (1997) Transcranial epidural approach to pituitary tumors extending beyond the sella. Neurosurgery 41:542–550 (discussion 551–552)
Youssef AS, Agazzi S, van Loveren HR (2005) Transcranial surgery for pituitary adenomas. Neurosurgery 57:168–175 (discussion 168–175)
Alleyne CH Jr, Barrow DL, Oyesiku NM (2002) Combined transsphenoidal and pterional craniotomy approach to giant pituitary tumors. Surg Neurol 57:380–390 (discussion 390)
Leung GK, Yuen MM, Chow WS, Tse PY, Lui WM (2012) An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas. Pituitary 15:237–241
Han S, Tie X, Qin X, Wang Y, Wu A (2014) Frontobasal interhemispheric approach for large superasellar craniopharyngiomas: do the benefits outweigh the risks. Acta Neurochir (Wien) 156:123–130 (discussion 130–131)
Han S, Ding X, Tie X, Liu Y, Xia J, Yan A, Wu A (2013) Endoscopic endonasal trans-sphenoidal approach for pituitary adenomas: is one nostril enough. Acta Neurochir (Wien) 155:1601–1609
Hardy J, Vezina JL (1976) Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol 15:261–273
Knosp E, Kitz K, Steiner E, Matula C (1991) Pituitary adenomas with parasellar invasion. Acta Neurochir Suppl (Wien) 53:65–71
Paluzzi A, Fernandez-Miranda JC, Tonya SS, Challinor S, Snyderman CH, Gardner PA (2014) Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 17:307–319
Cappabianca P, Cavallo LM, de Divitiis O, de Angelis M, Chiaramonte C, Solari D (2015) Endoscopic endonasal extended approaches for the management of large pituitary adenomas. Neurosurg Clin N Am 26:323–331
Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2013) Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary 16:435–444
Zada G, Laws ER Jr (2010) Simultaneous transsphenoidal and intraventricular endoscopic approaches for macroadenomas with extensive suprasellar extension: surgery from below, above, or both. World Neurosurg 74:109–110
Musleh W, Sonabend AM, Lesniak MS (2006) Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumors. Expert Rev Anticancer Ther 6(Suppl 9):S79–S83
D’Ambrosio AL, Syed ON, Grobelny BT, Freda PU, Wardlaw S, Bruce JN (2009) Simultaneous above and below approach to giant pituitary adenomas: surgical strategies and long-term follow-up. Pituitary 12:217–225
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11060_2017_2371_MOESM1_ESM.tif
Supplementary Figure 1. A 51-year-old female patient presented with visual loss and headache, and subsequently underwent single endoscopic transsphenoidal surgery. A, B: A preoperative MRI revealed a non-functioning GPA with suprasellar extension, as seen in the sagittal (A) and coronal (B) planes. C, D: A postoperative MRI showed near-total removal of the tumor, as seen in the sagittal (C) and coronal (D) planes. (TIF 1732 KB)
11060_2017_2371_MOESM3_ESM.tif
Supplementary Figure 2. A 66-year-old male patient presented with progressive visual loss and headache, and subsequently underwent transcranial surgery. The frontobasal interhemispheric approach was used. A, B: A preoperative MRI revealed a GPA with significant suprasellar intraventricular extension, although the intrasellar tumor was very small, as seen in the sagittal (A) and axial (B) planes. C, D: A postoperative MRI showed complete removal of the suprasellar tumor, as seen in the sagittal (C) and axial (D) planes. The intrasellar residual tumor was removed using a second-stage transsphenoidal approach (TIF 5155 KB)
Rights and permissions
About this article
Cite this article
Han, S., Gao, W., Jing, Z. et al. How to deal with giant pituitary adenomas: transsphenoidal or transcranial, simultaneous or two-staged?. J Neurooncol 132, 313–321 (2017). https://doi.org/10.1007/s11060-017-2371-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-017-2371-6